Pittsburgh-Based Rinovum® Women's Health Readies for Market PLSG Portfolio Company Receives FDA Authorization to Market The Stork™, Opens Headquarters and Launches Commerce Website
PITTSBURGH, April 16, 2013 /PRNewswire/ -- Rinovum Women's Health, a privately held women's health company dedicated to bringing products into the market that will enhance women's lives and empower them to take charge of their health, announced today that it has expanded staff, moved to its new Pittsburgh headquarters and launched its online presence as part of its growth and plan toward market launch. The launch was kicked off this morning with an appearance on The Balancing Act® airing at 7:00AM ET on Lifetime Television to discuss infertility and The Stork™. The feature will be rebroadcast on April 24th at 7:00AM ET. The Balancing Act® is America's only one hour morning show that's about women, for women, and trusted by women. The Balancing Act® inspires and empowers with entertaining and educational shows–which helps place women in the best position to achieve success in every area of their lives.
Rinovum's first product The Stork™ is a prescription Rx device driving towards a direct-to-consumer device for reproductive health to aid in natural fertility and conception in the privacy of the patient's home. The Stork™ product line gives women and couples healthcare products that will help them reach their reproductive goals.
"Today an astonishing 1 in 6 couples has difficulty conceiving. Our mission with The Stork™ is to give women and couples healthcare products that will help them reach their reproductive goals," said Steve Bollinger, President & CEO of Rinovum Women's Health. "The Stork™ is an FDA authorized medical device designed to assist with common fertility difficulties such as: Motility Issues with Sperm, Diminished Sperm Count (low sperm count) and Hostile Vaginal Environment. The Stork™ was created to help couples on their journey to parenthood."
"We are proud that Rinovum Women's Health has outgrown the PLSG Incubator and continues to add employees as they prepare to launch their first product to market," said John W. Manzetti, Pittsburgh Life Sciences Greenhouse President & CEO. "We look forward to their continued growth and sustainability as a successful Pittsburgh-based FDA authorized to market medical device and women's healthcare solutions company."
Steve Bollinger continued, "While developing The Stork™, we discovered that women are faced with a multitude of issues related to nutrition, fertility and general women's health. In their pre-teen years these issues begin with the onset of puberty, they continue with women during their fertile years and into the later stages of their lives. We aim to provide products that are easy-to-use, safe and a more economical way for a woman to address some of these issues."
SOURCE Rinovum Women's Health